MBBS MRCS PhD
Clinical Lecturer and Specialist Registrar in General Surgery
My research explores mechanisms of immunological activation and tolerance following transplantation. I am particularly interested in understanding why certain organs, specifically the liver, are less likely to undergo rejection following withdrawal of immunosuppressive medications. My work describes the central role of extracellular vesicles (EVs) released from transplanted tissues in eliciting and coordinating recipient immune responses. EVs released from the transplanted liver possess specific properties which can act to tip the immune response towards a state of tolerance. An understanding of these pathways can serve to guide the development of novel approaches to organ specific immunotolerance, thereby minimising the need for conventional, highly toxic immunosuppressive regimens. In collaboration with partners in industry, my current focus is on harnessing the inherent capacity of EVs for targeted delivery of bioactive molecules and engineering them to develop biotherapeutics in transplantation and in liver diseases.
Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
Glasbey JC. and Bhangu A., (2020), Journal of Clinical Oncology, JCO.20.01933 - JCO.20.01933
Delaying surgery for patients with a previous SARS-CoV-2 infection.
COVIDSurg Collaborative None., (2020), Br J Surg
Endoscopic vacuum therapy (EVT) in the management of oesophageal perforations and post-operative leaks.
Mastoridis S. et al, (2020), Minim Invasive Ther Allied Technol, 1 - 9
Impact of donor extracellular vesicle release on recipient cell "cross-dressing" following clinical liver and kidney transplantation.
Mastoridis S. et al, (2020), Am J Transplant
Endoscopic Vacuum Therapy (EVT) for Oesophageal Perforations and Leaks: The Oxford Experience
Mastoridis S. et al, (2020), BRITISH JOURNAL OF SURGERY, 107, 49 - 49